Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.

PaperCitations, authors & open-access status

Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 52 citations, 1995 year and closed oa status.

52
Citations
1995
Year
closed
OA Status

Related on ScholarIQ

Romain Guibert
Author
PubMed
Journal
Lipoproteins and Cardiovascular Health
Topic
Lipoproteins and Cardiovascular Health
Topic
Health Systems, Economic Evaluations, Quality of Life
Topic
Pharmaceutical Economics and Policy
Topic
470M+ articles · free account